Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 11, 2019 Off

Global Basil Essential Oil Market 2019-2023 | Increasing Demand for Organic and Cold-Pressed Basil Essential Oil to Boost Growth | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global basil essential oil market is expected to post a CAGR of close to 8% during…

April 11, 2019 Off

Healthcare CMO Market to 2027- Global Analysis & Outlook by Service and Geography – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Healthcare CMO Market to 2027- Global Analysis and Forecasts by Service; and Geography” report has been added to…

April 11, 2019 Off

Enanta Pharmaceuticals Presents New Preclinical Data on Compounds Targeting Hepatitis B Virus and Non-Alcoholic Steatohepatitis at The International Liver Congress™ 2019

By BusinessWire

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral…

April 11, 2019 Off

Pharmacy Times® Named Industry News Provider of the Year by American Pharmacy Purchasing Alliance

By BusinessWire

This marks the third consecutive year Pharmacy Times® has won CRANBURY, N.J.–(BUSINESS WIRE)–Pharmacy Times®, the leading media resource for pharmacists…

April 11, 2019 Off

AriBio Co., Ltd. Announces First Patient Dosing in Phase 2 Study of AR1001 for Alzheimer’s Disease

By BusinessWire

On April 11, 2019, AriBio Co., Ltd. announced the first patient dosing in their Phase 2 study of AR1001 for…

April 11, 2019 Off

Simulations Plus Releases ADMET Predictor® Version 9.5

By BusinessWire

New machine learning models and novel analysis methods address customer requests LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the leading provider…

April 11, 2019 Off

Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference Call

By BusinessWire

WILMINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CRL&src=ctag" target="_blank"gt;$CRLlt;/agt; lt;a href="https://twitter.com/hashtag/earnings?src=hash" target="_blank"gt;#earningslt;/agt;–Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2019 financial results…

April 11, 2019 Off

Gartner Says U.S. Pharmaceutical Brands Must Adopt a Patient-Centric Narrative to Improve Digital Strategies

By BusinessWire

Report Ranks Digital Performance of 88 U.S. Pharmaceutical Brands; 75 Percent Rank Above Average Despite Unprecedented Scrutiny and Regulation STAMFORD,…

April 11, 2019 Off

Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics

By BusinessWire

SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…

April 11, 2019 Off

Concert Pharmaceuticals to Present CTP-543 Phase 2 Interim Data in Alopecia Areata at 2019 World Congress for Hair Research Annual Meeting

By BusinessWire

LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that interim clinical data from its…

Posts pagination

Previous 1 … 5,888 5,889 5,890 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine